$APVO
Aptevo Therapeutics Inc
XNAS•Health Care•Pharmaceutical Preparations
$1.89
▲+2.72%+$0.050
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAptevo Therapeutics Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is APVO up today? It is at $1.89 (+2.72%), and our scanner flagged it 27 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment APVO spikes, and full due diligence on APVO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $APVO 27 times in the last 30 days. Create a free account to track $APVO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on APVO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for APVO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML, from an SEC filing. Read it →Latest filing424B4Final offering prospectus (424B4)Sep 3, 2026 · 16 days agoAcross every filing on file, supply equal to 373% of the tradeable float is in play - 373% has already been sold.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
6,444,858 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Niederhuber John Director | Other | 400 0.02% of company | n/a | 400 | n/a | Aug 6, 26 |
Kunz Barbara Lopez Director | Other | 400 0.02% of company | n/a | 400 | n/a | Aug 6, 26 |
Abdun-Nabi Daniel Director | Other | 400 0.02% of company | n/a | 400 | n/a | Aug 6, 26 |
White Marvin L Officer | Sold (automatic/other) | -406 0.02% of company | sold 24% | 1K | $2K at $4.07 | Aug 6, 26 |
White Marvin L Officer | Other | 2K 0.09% of company | added 100% | 2K | n/a | Aug 6, 26 |
Grant Grady Iii Director | Other | 400 0.02% of company | added 53% | 1K | n/a | Aug 6, 26 |
Huebner Dirk Officer | Sold (automatic/other) | -156 | sold 24% | 482 | $635 at $4.07 | Aug 6, 26 |
Huebner Dirk Officer | Other | 638 0.04% of company | n/a | 638 | n/a | Aug 6, 26 |
Kwon Soyoung Officer | Other | 638 0.04% of company | n/a | 638 | n/a | Aug 6, 26 |
Taylor Daphne Officer | Other | 638 0.04% of company | n/a | 638 | n/a | Aug 6, 26 |
Lamothe Jeffrey G. Officer | Other | 961 0.05% of company | n/a | 961 | n/a | Aug 6, 26 |
Harsanyi Zsolt Director | Other | 400 0.02% of company | n/a | 400 | n/a | Aug 6, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on APVO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for APVO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
APVO last traded at $1.89, up 2.72% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Aptevo Therapeutics Inc (APVO) is next expected to report earnings on Thursday, November 5, 2026, about 47 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The APVO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged APVO 27 times in the last 30 days.
APVO (Aptevo Therapeutics Inc) trades on XNAS, with a market cap of about $3M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge APVO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$APVO discussion
Sign in to ask a question or join the discussion.